Failure of AstraZeneca Trial Big Blow For Anti-Addiction Drugs: Report
NDTV
OUD is a chronic neurological disorder that causes compulsive, repeated use of opioid drugs, leading to prolonged self-administration.
The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications that treat addiction and withdrawal, according to a report on Wednesday.
OUD is a chronic neurological disorder that causes compulsive, repeated use of opioid drugs, leading to prolonged self-administration.
The company recently terminated the development of AZD4041 during a Phase II trial, as the orexin 1 receptor antagonist demonstrated a drug-drug interaction with an antifungal.
Users on platforms like X are pasting screenshots of their PAN cards issued 3-4 years ago having QR codes.
Union Minister Ramdas Athawale has said Eknath Shinde was "unhappy" after the BJP finalised Devendra Fadnavis as its Chief Minister choice
Enviro Infra Engineers IPO was open for bidding from November 22 to November 26
The Mahayuti cruised to victory in last week's Maharashtra Assembly election winning 235 of 288 Assembly seats; the BJP won a record 132 on its own.
During the chase, the suspects fired at the cops, after which the police opened fire in retaliation.
Hardeep Singh Puri noted that the increase is influenced by global price dynamics and availability.
The senior lawyer said Congress must put out credible evidence before demanding a JPC probe
Parliament Winter Session Day 2 Live Updates: Discussions of the Wayanad landslide, Waqf bill and Sambhal violence will be the focus.
Wrapped in clothes and shivering in the biting cold, the infant's cries caught the attention of nearby residents, who immediately informed the police.
Mr Bhagwat said the life force appeared on January 22, in a veiled reference to the consecration of the Ram Temple in Ayodhya.